About Us

Dan Hecht is the CEO of MDVIP with more than two decades of experience in the healthcare arena. Mr. Hecht’s healthcare management and business acumen have been instrumental in positioning MDVIP as the national leader in personalized healthcare. Under his guidance, MDVIP continues to innovate and expand the services and benefits offered to its members and affiliated physicians to transform the delivery of primary care in this country. Mr. Hecht previously held a variety of healthcare leadership positions with Procter & Gamble including General Manager, North American Pharmaceuticals, and Global Franchise Leader, based in P&G’s global headquarters in Cincinnati, Ohio, and in several countries in Europe including Germany and the United Kingdom. He has led the successful development and commercialization of a wide range of products in therapeutic areas including respiratory, cardiac, anti-infective, gastrointestinal and bone. Mr. Hecht received his B.A. and M.B.A. with concentrations in finance and marketing from the University of Rochester.

Mark Murrison leads all aspects of MDVIP’s consumer marketing, business development and innovation efforts to establish MDVIP as the most recognized brand in the consumer health services space. He was the Procter & Gamble executive who identified the potential of MDVIP to become a transformational consumer health brand and led P&G to make its first-ever investment in a health services company in 2006. From 2006 through 2009, Mr. Murrison was the P&G executive who helped MDVIP achieve significant business growth resulting in P&G’s full acquisition of MDVIP in December 2009. He has 16 years of experience in marketing and brand management with P&G where he has held a variety of leadership positions in healthcare and P&G FutureWorks, the company’s new business incubator. Mr. Murrison has directed the P&G efforts to enter new consumer healthcare categories and established several new consumer health businesses through external partnerships, joint ventures, acquisitions and equity investments – including MDVIP, Swiss Precision Diagnostics and Crest Spinbrush. He serves as a company spokesperson for MDVIP and is widely regarded as an innovator and thought leader in health care who frequently speaks at business and healthcare conferences. Prior to joining P&G, he worked on Capitol Hill serving as director of legislative policy for several members of Congress. Mr. Murrison received his M.B.A. from the University of Texas in Austin and a B.S. in business from Kansas State University.

Dr. Andrea Klemes is the Medical Director of MDVIP. She also serves as the executive and organizational leader of MDVIP’s Medical Advisory Board that supports quality and innovation in the delivery of the healthcare model drawing expertise from the affiliated physicians. Dr. Klemes oversees MDVIP’s impressive outcomes data and research including hospital utilization and readmission statistics, quality of disease management in the MDVIP network and the ability to identify high-risk patients and intervene early. She is instrumental in the adoption of the Electronic Health Record use in MDVIP-affiliated practices and the creation of the data warehouse. Dr. Klemes is board certified in internal medicine and endocrinology and a fellow of the American College of Endocrinology. Dr. Klemes received her medical degree from the New York College of Osteopathic Medicine. She completed an internal medicine residency at Cabrini Medical Center in Manhattan, New York and an Endocrine and Metabolism Fellowship at the Medical College of Georgia in Augusta. Prior to joining MDVIP, Dr. Klemes worked at Procter & Gamble in the areas of personal healthcare, women’s health and digestive wellness and served as North American Medical Director for bone health. She spent 10 years in private practice specializing in endocrinology and metabolism in Tallahassee, Florida. In addition, Dr. Klemes held leadership roles with the American Medical Association, Florida Medical Association and as Medical Director of the Diabetes Center in Tallahassee and Panama City, Florida, as well as Chief of the Department of Medicine at Tallahassee Community Hospital. She has been a consultant and frequent lecturer and has completed broad clinical research in diabetes and osteoporosis and published extensively.

Prior to joining the MDVIP executive team, Dr. Kaminetsky was a founding partner in a primary care practice based in Boca Raton, Florida and now serves as a national spokesperson for MDVIP. He was the second physician to open an MDVIP-affiliated practice, and he is the first physician to participate in the MDVIP physician retirement program. Dr. Kaminetsky is a passionate advocate for preventive care and wellness on the federal level, having testified before the Joint Economic Committee of the U.S. Congress. Dr. Kaminetsky is a graduate of Albert Einstein College of Medicine and a former assistant professor at New York University School of Medicine. He is also a member of the prestigious Alpha Omega Alpha medical honor society and served as Chief Resident during his internal medicine residency at Bellevue-New York University. Dr. Kaminetsky is board certified in internal medicine and nephrology.

Roy Harris has been an integral part of the MDVIP management team since 2003. Prior to joining MDVIP, Mr. Harris was an associate in the Fort Lauderdale office of Broad and Cassel as a member of the firm’s Health Law Practice Group. Additionally, Mr. Harris has lectured students, attorneys and healthcare providers on various health law topics. He received his undergraduate degree in political science from the University of Florida. Mr. Harris is a magna cum laude graduate of the Nova Southeastern University Shepard Broad Law Center which he attended as a Goodwin Academic Scholar.